IN 1934, when Sir Charles Dodds gave the Goulstonian Lectures, there were only three hormones under the control of the anterior pituitary, the chemical constitution of which was accurately known. Adrenaline was of course an addition to these. Additions which can now be made include at least 10 steroidal substances, with very numerous additional metabolites as well as insulin, tri-iodothyronine and nor-adrenaline and other hormones about which we have varying degrees of detailed information.
Parkes's Presidential Address to the Section (1950) the estimation of the hormones in blood was almost entirely a problem for the future. Nevertheless, in spite of the difficulties involved, he made a strong plea for greater attention to be paid to this question. It would be superfluous to mention all the hormones which can now be estimated in blood with an acceptable degree of accuracy, but they include some such as insulin, corticotropin and thyrotropin dependent still on bio-assay techniques, and others such as steroids and catechol amines where chemical methods may be accurately applied.
The rapid improvement in the chemical and physicochemical methods available is due particularly to development of chromatographic methods, especially the use of paper, and to the use of radioactive isotopic techniques. After many years' effort by many of us, and especially by Dr. R. K. Callow and later by Dr. B. W. Klyne, the work is greatly facilitated by the availability through the courtesy of the Medical Research Council of a large range of steroid reference substances. These chemically pure substances are required particularly in the establishment of the validity of analytical methods, as well as in many other ways.
More critical evaluation of the methods used whether chemical or biological is now expected and is a necessary requirement in the correct interpretation of analytical data.
We must acknowledge a considerable debt to our colleagues in the Edinburgh School for their constant efforts in recent years to bring home to us the importance of this matter. It is now generally accepted that a reliable method should conform to rigid requirements of specificity, reproducibility, accuracy, sensitivity and then convenience. Lastly our knowledge of the normal has greatly increased and facilitates our interpretations.
Parallel with these advances in technology have come developments in the pathophysiology of many of the hormones which have important bearings on the interpretation of our data.
That the truth of this assertion is only too obvious can be seen in the report of the valuable Ciba Colloquium held in 1957 on "Hormones in Blood". Hormone estimations are of great value to the clinical endocrinologist if they give information about the activity of the gland secreting the hormone and the amount of hormone activating the end organ or organs, thus producing clinical changes. For many years our thoughts have been confined to the direct relationship between this gland activity and the resulting end-organ effects, but it will be clear that the time has now arrived when a more critical evaluation of the situation must be made, and factors modifying this relationship assessed.
ProcAedings of the Royal Sooiety of Medicine
To begin with I should like to refer to an over-schematized diagram to indicate points for discussion ( Fig. 1 ). Commencing at the top with the liberation of the hormone from the secreting gland into the blood stream, it may be present in the plasma in a form involving some kind of binding to protein. In most cases a large part of the hormone secreted is metabolized in some way in the liver and other tissues. Whilst a small proportion is excreted in the urine unchanged, metabolites are generally the main excretory products.. Passage of the hormone from the blood via the-tissue flui,d occurs before ultimately reaching the end organ or target gland. There are a number of points (marked H in Fig. 1 ) where there is some evidence that the processes may be affected by other hormones simultaneously present in the system. Although even less is known of the subject, we must also be prepared for modifications to occur in the balance on account of the operation of nutritional and other factors. We are now approaching the time when measurements of secretion rate will become more commonplace and be practicable for clinical purposes. It must, however, be appreciated that quite frequently one may be concerned with conditions where hormone secretion is fluctuating at varying rates, depending upon the conditions and the glands involved. I have in mind such states as thyrotoxicosis, Cushing's syndrome, hyperparathyroidism, hyperinsulinism, &c., and we are especially interested in the times when the secretion rate is raised, rather than those when it may be normal. Present methods of determining the secretion rate may be divided into indirect and direct techniques. The measurement of the uptake rate of radioactive inorganic iodine and the amount liberated into the blood in protein-bound form is an example of the indirect method. It is well known that the interpretation of such changes is open to a variety of hazards if one wishes to deduce the actual rate of secretion and total amount of hormone liberated from the gland. Apart from problems associated with the size of the inorganic iodine pool, perhaps more important are those arising from enzymatic abnormalities in the synthesis of thyroi hormone in certain myxcedematous states, an analogous situation to that arising in the adrenal where corticoid synthesis may be blocked owing to the failure of hydroxylating enzymes which are required in the synthetic pathway.
In some instances secretion rates may be measured by more direct techniques. Firstly, calculations may be made on the basis of the amount of suitable metabolites excreted in the urine after the administration of a quantity of precursor. In this way Brown (1957> has been able to compute the secretion rate of cestradiol and aestrone throughout the normal menstrual cycle. One must be cautious in such interpretations for under some conditions the proportion of the metabolites formed from the parent hormone may undergo variations. Also the time taken to collect a sufficient quantity of metabolite may be long and the administration of sufficient quantity of precursor may interfere with the conditions to a material degree. By the administration of a small quantity of isotopically labelled precursor, necessitating only the determination of the specific activity of the chosen metabolite(s), these objections may be partially overcome.
Still better, in some instances, there is a more direct approach. The rate of decrease of specific activity of the hormone may be determined in the plasma after injection of labelled hormone of known activity. With a knowledge of the actual hormone level at some stage during the measurement, and making several assumptions, the secretion rate may be calculated. Changes in the slope of decline of the specific activity in the plasma may be used as an indication of changes of secretion rate. Such a method is capable of indicating and confirming the diurnal variation of secretion of cortisol by the adrenal gland (Petersen and Wyngaarden, 1956).
The potential importance to the clinician of protein binding of hormones in the plasma -is as yet difficult to assess. It influences the amount of hormone freely available on account of the avidity of binding, the availability of the protein to which the hormone is bound or possibly by competitive binding, for instance by different steroids. It has for some years been recognised that cestrogens undergo an association with proteins, but curiously enough the protein binding of these steroids has at present become a particularly controversial matter. More recent knowledge of thyroid and corticoid hormones appears to indicate that a proportion of the hormone is firmly bound to globulin, a further portion is more loosely bound to albumin, a kind of reserve overflow mechanism, and that quantities exceeding this capacity are freely available. Such a state of affairs would tend -to limit the accumulation in the plasma of high concentrations of hormone. There is even evidence that polypeptides, such as the antidiuretic hormone, and thyrotropin are associated with plasma proteins. That cortisol concentration in extracellular fluid is below -that of the plasma level is now well known (Cope and Hurlock, 1953) . Our knowledge of the fate of hormones in the tissues themselves is extremely scanty.
In the case of insulin for instance some kind of association with muscle tissue occurs which -may be an association with the protein of the tissue: it is not easily washed away from rat diaphragm preparations immersed in its solution. It would thus appear that in any consideration of the quantity of hormone reaching its site of action a complete series of 'equilibria must be envisaged in transference of the hormone from its site of secretion.
Not only are the free hormones protein bound, but conjugates of corticoids, cestrogens and dehydroepiandrosterone are also known to be transported in this way in the plasma.
At present it is difficult to see any obvious purpose in this but it leads me to mention the significance of hormone metabolism in our consideration of blood levels. The general nature of metabolic inactivation is too widely recognised to dwell on this aspect, but oxidation, reduction, conjugation and other changes are general reactions which are well known to occur, largely in the liver. The limitation of the rate of these reactions, due to impairment of normal function of the liver in this respect, is leading to the emergence of a new type of endocrinological abnormality. The simple notions hitherto held concerning the role of the liver in producing clinical evidence of cestrogen excess, such as gynecomastia, may well merit further investigation, but we also have for example the recently recognized occurrence of signs of excess of adrenal hormones in juvenile cirrhotics (Sherlock, 1958) .
The new knowledge gained of the changes in adrenal hormones in pregnancy is of particular -interest. The use of recent methods for measuring the amount of corticoid metabolites in the urine, principally conjugates, has indicated much less urinary increase of these steroids than had been observed with early techniques, which are now known to have measured mostly free steroids (Martin and Mills, 1958) . Measurements of blood cortisol on the other hand made by them and of the turnover rate of 14C cortisol have shown an increased blood level which is not apparently due to increased gland secretion and therefore is presumably due to decreased metabolism (Migeon et al., 1957) . This is perhaps the best example of a type of abnormality which justifies the most critical analysis of the significance of levels of hormones in the blood, or for that matter of urine excretion values. Although pregnancy has been referred to by some as a physiological Cushing's syndrome it is perhaps more remarkable that its resemblances to this syndrome are so slight! In this connexion it has recently been found that cestrogens have the effect of raising the level of cortisol in the blood, but in protein-bound and not free form . We must also take into account the possibility that hormone metabolites, and not only the hormones themselves, may possess physiological functions. This is perhaps indicated for instance by the biological activities manifest by thyroxine degradation products, such as the pyruvic acids and their derivatives.
It is surprising that apparently such large quantities of waste products arise from the original hormone secreted. Thus the major part of steroid hormones secreted each day is lost in some form by renal excretion, and the major part of their degradation has apparently occurred in a way which is unrelated to its specific actions. The handling of hormones and their metabolites by the kidney is revealing itself as a complex and many-sided process. Steroid glucuronide complexes are apparently freely filtrable, whereas the clearance of dehydroepiandrosterone sulphate for instance is very much smaller. Similarly the clearance of free corticoids is only a fraction of that of the glucuronide complexes. The relative roles of tubular reabsorption and protein binding in the production of this discrepancy are not yet known. To date knowledge of the renal pathology of hormone excretion has indicated chiefly the effect of filtration failure on the accumulation of conjugated steroids in the blood. In the case of cortisol there is also a smaller change in the free hormone which may be attributable to the level of the equilibrium with its metabolites (Englert et al., 1958) . A little is known, however, of what happens to hormones remaining in the blood stream with respect to their availability to the tissues. A beginning has been made with the use of isotopically labelled hormones such as anterior pituitary hormones, progesterone and insulin to determine how they are localized. It seems that the proportions localized in the expected site may be small and larger quantities which in some instances appear in liver and kidneys may be undergoing metabolic breakdown. But surprises may well be coming. In a very recent report it was shown that tritium-labelled insulin was prominently localized in the anterior pituitary and adrenals (Holt and Holt, 1958) .
Before we can interpret the blood level of a hormone in terms of its tissue effects we need to know something of the mode of action of the hormone in association with enzymes and therefore of the influence of other hormonal and non-hormonal factors on this process. The wasteful turnover of energy which can be excited by thyroxine is somewhat startling at first sight. Its physiological significance has been questioned (Pitt-Rivers, 1958) but it may have more important pathological implications. Enzymatic reactions in the synthesis of nucleoprotein and protein in the uterus are now known to be directly stimulated by cestrogen (Mueller et al., 1958) as also is hydrogen transfer to diphosphopyridine nucleotide (Villee and Hagerman, 1958) . It must be expected that such end reactions of hormones will be influenced in other ways than by the hormones themselves. Such factors may include nutritional ones, which are being increasingly recognized as being of importance in connexion with hormone production. The effects of severe malnutrition on atrophy of the reproductive organs is perhaps an extreme example but a nearer one is the ever intriguing problem of the reduced function of the endocrine system which may occur in anorexia nervosa. More specifically in the guinea-pig for example ascorbic acid deficiency may act as an inhibitor and then when more acute as an excitor of adrenal cortical function .
The amount of one particular hormone available may have repercussions upon the secretion of another. The effects under this heading of the "push-pull" principle are now taken as a matter of course, but the interaction may extend more widely than this. For instance we have recently found that under conditions where thyroid and corticotropin secretions are both reduced in the same patient the response to a constant replacement dose of corticotropin may be greatly enhanced by the simultaneous administration of tri-iodothyronine (Brooks, Hetzel, McSwiney and Prunty, 1957) . The increased secretion of thyroid hormone not only increases the rate of cortisol secretion but also appears to increase its rate of metabolism (Cope and Black, 1958; Samuels et al., 1957) . We are not concerned with the specificity of the mode of action of the thyroid hormone in these effects, but the fact that there is an interdependence is of importance to us. The responsiveness of the female rat adrenal to corticotropin bears some relation to the amount of cestrogen available (Clayton and Hammant, 1957) .
There are in addition effects of hormones on protein binding of other hormones, as for instance the alteration by cestrogen of thyroxine binding, and probably also on the metabolism of other hormones. Mention has already been made of the altered corticoid metabolism in pregnancy and it seems possible that cestrogens are also connected with this phenomenon.
One of the best examples of the complexity of hormone interaction is perhaps in the mammary gland, where under experimental conditions gland growth in the rat is influenced by at least 5 hormones, including a sufficiency of adrenal corticoid. This involved synergism reveals considerable possibilities in the phenomena at present loosely grouped under the heading of end-organ sensitivity. It is perhaps hardly surprising that our attempts to explain the occurrence of gynwcomastia in its various clinical settings are as yet so feeble. Problems such as this can now only be regarded as being in the stage of definition.
Another that is equally intriguing is the unresponsiveness of some individuals to large doses of androgens. This was touched upon by our President last year (Armstrong, 1958) and more recently by Hellinga (1958) . I too have seen this phenomenon, for example in a hypergonadotropic eunuchoid, with female nuclear sex, who is apparently exceedingly refractory to testosterone therapy.
The last item of the diagrammatic scheme of blood hormone relationship is as yet perhaps the most speculative (Fig. 1) . I refer to the problem of antihormones and do not mean the type of resistance commonly recognized, to impure heterologous hormones, for instance the human unresponsiveness to growth hormones other than of human origin, but to true hormone inhibitors. An approach to this problem is currently being made in the case of insulin but we have as yet only a glimpse of the possibilities. Here again it seems that blood proteins may play an important role.
But much of what I have referred to must be regarded as an indication of the qualifications the clinician of the future must bear in mind when he interprets data of blood hormone levels in his patients. In spite of the complication of the subject, the clinical endocrinologist should count himself fortunate in comparison with some of his colleagues in other fields, in that there are already in existence so many measurable parameters to guide him in his problems of both diagnosis and therapy. I would like now to consider several specific features of adrenal cortical abnormalities with which I have been recently concerned; it is hoped to publish more details elsewhere.
In the first place data from a group of 11 patients considered to have primary aldosteronism have demonstrated that there was a considerable fluctuation in the day-to-day excretion of aldosterone. After allowing for this it did not seem possible to correlate the excretion levels either with the capacity for renal filtration or with the presence or absence of small adrenal cortical adenomas. Secondly there occurred in a few patients with Cushing's syndrome severe alkalosis, hypokalmmia and potassium depletion. Two patients were described who secreted excess cortisol but had little corticosterone in the plasma and excreted low normal quantities of aldosterone. Treatment of one of these with a pituitary implant of 9OYt abolished the hypersecretion of cortisol and severe abnormality of potassium metabolism without reducing the aldosterone excretion farther. The occurrence of these changes in such patients and of similar changes in primary aldosteronism in instances where there was no detected hormone abnormality seems to raise the possibility that a hitherto unrecognized hormonal substance might be involved. Some other unusual clinical findings in patients with increased hormone production by the adrenal cortex were then discussed. The first of these related to a patient in whom the usual stigmata of Cushing's syndrome were absent in spite of a marked increase of plasma hydrocortisone and urinary 17-ketogenic steroids produced from an adrenal carcinoma (Brooks, McSwiney, Prunty and Wood, 1957) .
The second case also showed similar evidence of increased cortisol production and I am indebted to Dr. Edmunds and his colleagues for much of the information and photographs (Edmunds et al., 1958) . The patient was 42 and complained of lassitude and was somewhat overweight with impaired sugar tolerance but was not hypertensive. Apart from this, she showed none of the typical signs of Cushing's syndrome but a remarkable pigmentation had recently developed, involving the buccal mucosa and this together with the lassitude suggested to them the possibility of Addison's disease.
There was pronounced hypokalemic alkalosis and a very large potassium deficit was demonstrable. She was found by Dr. Clayton to have a considerable excess of corticotropin in the plasma (Clayton, 1958 , Patient C) but Professor Landgrebe was not able to demonstrate the presence of melanophore stimulating hormone (MSH).
Subtotal adrenalectomy was performed with complete reversal of all the patient's symptoms and signs, including disappearance of the abnormal pigmentation. The features of this case appear to contradict all the "laws" of endocrinology. There was bilateral adrenal hyperplasia involving only the fasciculata and from the biochemical point of view the conditions were typical of those of Cushing's syndrome. The pigmentary changes are quite inexplicable on current theories, indeed if corticotropin and not MSH was involved in the pigment formation one is at a loss to understand the decrease of pigment after adrenalectomy, when it would be expected that even more corticotropin might be secreted. Unfortunately, we have not as yet any information on the corticotropin level in the blood following adrenalectomy.
The existence of another interesting group of patients has recently been emphasized by Kovach and Kyle (1958) . These are individuals with a fulminating type of Cushing's syndrome due to adrenal hyperplasia, and frequently with disturbances of potassium metabolism, in whom are also found bronchial oat cell carcinomas. Some details were given of the author's personal experience of one of the first of this group of patients, who at the time was regarded as a medical curiosity, and was one of the two patients reported by Thorne (1952) .
Finally very recent studies of another aspect of adrenal abnormality in young women with hirsutism were discussed. It would seem that there is reasonable evidence to suppose that there is some degree of adrenal abnormality in the Stein-Leventhal syndrome, a greater degree in some patients with simple hirsutism, a still greater degree in some occasional women developing signs of virilism after puberty and a maximal degree in patients with congenital adrenal hyperplasia. It still remains to be determined how far these patients differ in kind rather than degree. Although we are left with the impression that there is no indication of an ovarian androgen in the Stein-Leventhal patients, we still have to take into account the consequences of the secretion of small amounts of a very active androgen such as testosterone. It is quite possible for this, or some unknown androgen, to be secreted in amounts sufficient to cause signs of virilization in sensitive persons and yet in quantities insufficient to be detected by our methods as any of the metabolites we have examined. Such a state of affairs would offer a better explanation of our findings which could be taken as indicating metabolic disturbances accompanying but not directly indicating the fundamental abnormality.
I have discussed these adrenal abnormalities at some length because of the interesting problems they present and because they do not appear to be entirely explicable in the light of current knowledge. The ability to carry out hormone assays would seem in the beginning to confirm preconceived ideas because we naturally tend to apply them in circumstances where we expect to find a postulated abnormality. As we proceed less typical situations are discovered and some of them no doubt must lead us to question the complete validity of our original ideas. The evolution of such developments is the essence of progress.
